Patent Assignment
Reel/Frame 043202/0977
Change of Name
Recorded: 2017-08-04
Pages: 3
Assignor
EURAND INCORPORATED
Executed: 2011-07-12
Assignee
APTALIS PHARMATECH INC.
845 CENTER DRIVE, VANDALIA, OHIO, 45377
Covered Property
(1)
Orally Administered Corticosteroid Compositions
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 4, 2017
From: PERRETT, STEPHEN; COHEN, FREDERIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 043202/0964 →
Change of Name
Aug 4, 2017
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 043203/0001 →
Assignment of Assignor's Interest
Dec 4, 2018
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT I, L.P,
Reel/Frame 047672/0450 →
Security Interest
Dec 18, 2018
From: ADARE DEVELOPMENT I, L.P.
To: BANK OF MONTREAL
Reel/Frame 047807/0967 →
Change of Name
Jul 16, 2020
From: ADARE DEVELOPMENT I, L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 053228/0251 →
Release of Security Interest Recorded at Reel/Frames 037246/0313, 047807/0967, 053474/0276
Sep 22, 2020
From: BANK OF MONTREAL, AS COLLATERAL AGENT
To: ADARE PHARMACEUTICALS, INC.; ADARE DEVELOPMENT I, L.P.; ADARE PHARMACEUTICALS USA, INC.
Reel/Frame 053852/0697 →
Corrective Assignment to Correct the Application Number, Patent Issue Date and the Title Previously Recorded at Reel: 053228 Frame: 0251. Assignor(S) Hereby Confirms the Assignment.
Oct 5, 2020
From: ADARE DEVELOPMENT I, L.P.
To: ADARE PHARMACEUTICALS US, L.P.
Reel/Frame 054003/0694 →
Change of Name
Apr 19, 2021
From: ADARE PHARMACEUTICALS US, L.P.
To: ELLODI PHARMACEUTICALS, L.P.
Reel/Frame 055966/0656 →